Table 1 Clinical pathological variables of breast cancer patients

From: Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p

Variables Classifier Low Hsa_circ_001783 High Hsa_circ_001783 Total P value RR
   n = 98 n = 38 n = 136   
Age ≤40 years 16 7 23 0.77 0.864
  >40 years 82 31 113   
Menopause Yes 63 27 90 0.454 0.733
  No 35 11 46   
Tumor size ≤2 cm 38 3 41 <0.001 7.389
  >2 cm 60 35 95   
LN status Negative 53 3 56 <0.001 13.741
  Positive 45 35 80   
TNM stage I 31 1 32 <0.001 17.119
  II–III 67 37 104   
Tumor grade I 9 2 11 0.727 1.82
  II–III 89 36 125   
ER Negative 22 19 41 0.002 0.289
  Positive 76 19 95   
PR Negative 19 19 38 <0.001 0.241
  Positive 79 19 98   
HER2 Negative 82 35 117 0.203 0.439
  Positive 16 3 19   
Molecular subtype TNBC 10 21 31 <0.001 0.092
  Non-TNBC 88 17 105   
Ki-67 ≤14% 45 8 53 0.008 3.184
  > 14% 53 30 83   
  1. LN lymph node, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2, RR relative risk, TNBC triple-negative breast cancer